Outcomes of Intravitreal Triamcinolone Acetonide Injection in Patients With Diabetic Macular Edema
INTRODUCTION: To evaluate the effectiveness of intravitreal triamcinolone acetonide injection (IVTA) in chronic diabetic macular edema (DME) and to assess complications of treatment. METHODS: 4 mg/0.1ml triamcinolone acetonide was injected into the intravitreal cavity of 34 eyes of 20 patients. 7 m...
Main Authors: | Lokman Balyen, Kaan Ünlü, Lütfiye Seçil Deniz Balyen |
---|---|
Format: | Article |
Language: | English |
Published: |
Van Yuzuncu Yil University, School of Medicine
2018-01-01
|
Series: | Van Tıp Dergisi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-91300 |
Similar Items
-
Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema
by: Zakaria YG, et al.
Published: (2022-03-01) -
Intravitreal Triamcinolone Acetonide for Patients with Macular Edema due to Branch Retinal Vein Occlusion
by: Kai-Chun Cheng, et al.
Published: (2006-07-01) -
Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
by: Chiung-Yi Chiu, et al.
Published: (2021-01-01) -
Comparison between intravitreal ranibizumab injection and posterior subtenon triamcinolone acetonide injection at time of cataract surgery for prevention of progression of diabetic macular edema
by: Mahmoud Mohammed Ahmed Ali Khalil, et al.
Published: (2022-12-01) -
Comparison of intravitreal bevacizumab and triamcinolone acetonide theraphies for diffuse diabetic macular edema
by: Sibel Aksoy, et al.
Published: (2015-06-01)